Cargando…
MicroRNA-200c reverses drug resistance of human gastric cancer cells by targeting regulation of the NER-ERCC3/4 pathway
Gastric cancer (GC) is one of the most common types of malignant tumor. Due to the lack of effective drugs and the emergence of chemotherapy resistance, patients with GC exhibit a poor prognosis and low survival rate. MicroRNAs (miRNAs/miRs) serve an important role in drug resistance of different ty...
Autores principales: | Li, Min, Gao, Min, Xie, Xiaoque, Zhang, Yiyin, Ning, Jie, Liu, Pingping, Gu, Kangsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539893/ https://www.ncbi.nlm.nih.gov/pubmed/31289483 http://dx.doi.org/10.3892/ol.2019.10304 |
Ejemplares similares
-
MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells
por: Xie, Xiaoque, et al.
Publicado: (2019) -
MicroRNA-200c as a prognostic and sensitivity marker for platinum chemotherapy in advanced gastric cancer
por: Li, Min, et al.
Publicado: (2017) -
MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein
por: Wei, Xiaoli, et al.
Publicado: (2019) -
Correlation between miR-138-5p expression and efficacy of platinum-based chemotherapy in advanced gastric cancer patients
por: Ning, Jie, et al.
Publicado: (2020) -
ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients
por: Li, Yangkai, et al.
Publicado: (2013)